Physical and Functional Interaction between the Human T-Cell Lymphotropic Virus Type 1 Tax₁ Protein and the CCAAT Binding Protein NF-Y

REFERENCES

• Adya, N., L.-J. Zhao, W. Huang, I. Boros, and C.-Z. Giam. 1994. Expansion of CREB’s DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB. Proc. Natl. Acad. Sci. USA 91:5642–5646.
   PubMedGoogle Scholar
• Agoff, S. N., J. Hou, D. I. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84–87.
   PubMed Web of Science ®Google Scholar
• Akari, H., Y. Goto, and T. Shinjo. 1995. Detection of the cellular membrane proteins on human T cell leukemia virus type I. Arch. Virol. 140:375–382.
   PubMedGoogle Scholar
• Anderson, M. G., and W. S. Dynan. 1994. Quantitative studies of the effect of HTLV-I Tax protein on CREB protein-DNA binding. Nucleic Acids Res. 22:3194–3201.
   PubMed Web of Science ®Google Scholar
• Armstrong, A. P., A. A. Franklin, M. N. Uittenbogaard, H. A. Geibler, and J. K. Nyborg. 1993. Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc. Natl. Acad. Sci. USA 90:7303–7307.
   PubMed Web of Science ®Google Scholar
• Ausubel, F. M., R. Brent, R. Kingston, D. Moore, J. J. Seidman, J. Smith, and K. Struhl. 1994. Current protocols in molecular biology. John Wiley and Sons, New York, N.Y.
   Google Scholar
• Baranger, A. M., C. R. Palmer, M. K. Hamm, H. A. Giebler, A. Brauweller, J. K. Nyborg, and A. Schepartz. 1995. Mechanism of DNA-binding enhancement by the human T-cell leukemia virus transactivator Tax. Nature (London) 376:606–608.
   PubMed Web of Science ®Google Scholar
• Baxevanis, A. D., G. Arents, E. N. Moudrianakis, and D. Landsman. 1995. A variety of DNA-binding and multimeric proteins contain the histone fold motif. Nucleic Acids Res. 23:2685–2691.
   PubMed Web of Science ®Google Scholar
• Boulikas, T. 1993. Nuclear localization (NSL). Crit. Rev. Eukaryotic Gene Expression 3:193–227.
   PubMedGoogle Scholar
• Brauweiler, A., P. Garl, A. A. Franklin, H. A. Giebler, and J. K. Nyborg. 1995. A molecular mechanism for human T-cell leukemia virus latency and Tax transactivation. J. Biol. Chem. 270:12814–12822.
   PubMedGoogle Scholar
• Brodsky, F. M., and L. E. Guagliardi. 1991. The cell biology of antigen processing and presentation. Annu. Rev. Immunol. 9:707–744.
   PubMed Web of Science ®Google Scholar
• Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. USA 90:2532–2536.
   PubMed Web of Science ®Google Scholar
• Bryans, M., L. M. Lucas, T. J. Knoboch, N. M. Wilkie, and J. C. Lang. 1995. Regulation of FGF-4 enhancer activity by transcription factor NF-Y. Bio-chem. Biophys. Res. Commun. 211:519–527.
   PubMedGoogle Scholar
• Chang, Z.-F., and C.-J. Liu. 1994. Human thymidine kinase CCAAT-binding protein NF-Y, whose A subunit expression is serum-dependent in human IMR-90 diploid fibroblasts. J. Biol. Chem. 269:17893–17898.
   PubMedGoogle Scholar
• Chen, H., J. Campisi, and R. Padmanabhan. 1996. SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor. J. Biol. Chem. 27:13959–13967.
   Google Scholar
• Clemens, K. E., G. Piras, M. F. Radonovich, K.-S. Choi, J. F. Duvall, J. DeJong, R. Roeder, and J. N. Brady. 1996. Interaction of the human T-cell lymphotropic virus type 1 Tax transactivator with transcription factor IIA. Mol. Cell. Biol. 16:4656–4664.
   PubMedGoogle Scholar
• Cogswell, J. P., N. Zeleznik-Le, and J. P.-Y. Ting. 1991. Transcriptional regulation of the HLA-DRA gene. Crit. Rev. Immunol. 11:87–112.
   PubMedGoogle Scholar
• Daenke, S., S. Nightingale, J. K. Cruickshank, and C. R. M. Bangham. 1990. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J. Virol. 64:1278–1282.
   PubMedGoogle Scholar
• Dittmer, J., S. D. Gitlin, R. L. Reid, and J. N. Brady. 1993. Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1. J. Virol. 67:6087–6095.
   PubMed Web of Science ®Google Scholar
• Dorn, A., J. Bollekens, A. Straub, C. Benoist, and D. Mathis. 1987. A multiplicity of CCAAT box-binding proteins. Cell 50:863–872.
   PubMed Web of Science ®Google Scholar
• Filatov, D., and L. Thelander. 1995. Role of a proximal NF-Y binding promoter element in S phase-specific expression of mouse ribonucleotide reductase R2 gene. J. Biol. Chem. 270:25239–25243.
   PubMedGoogle Scholar
• Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lym-photropic virus type I infection. Blood 86:3619–3639.
   PubMed Web of Science ®Google Scholar
• Franklin, A. A., and J. K. Nyborg. 1995. Mechanism of Tax regulation of human T cell leukemia virus type I gene expression. J. Biomed. Sci. 2:17–29.
   PubMedGoogle Scholar
• Franklin, A. A., M. F. Kubik, M. N. Uittenbogaard, A. Brauweiler, P. Utaisincharoen, M.-A. H. Matthews, W. S. Dynan, J. P. Hoeffler, and J. K. Nyborg. 1993. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB). J. Biol. Chem. 268:21225–21231.
   PubMed Web of Science ®Google Scholar
• Fukushima, A., and H. Ueno. 1995. The relationship between HTLV-1-infected cell lines and uveitis. Graefes. Arch. Clin. Exp. Ophthalmol. 233:231–235.
   PubMedGoogle Scholar
• Gazzolo, L., and M. Duc Dodon. 1987. Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature (London) 326:714–717.
   PubMedGoogle Scholar
• Gessain, A., F. Saal, O. Gout, M. T. Daniel, G. Flandrin, G. de The, J. Peries, and F. Sigaux. 1990. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood 75:428–433.
   PubMed Web of Science ®Google Scholar
• Grassman, R., S. Berchtold, I. Radant, M. Alt, B. Fleckenstein, J. G. Sodroski, W. A. Haseltine, and U. Ramstedt. 1992. Role of human T-cell leukemia virus type I X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:4570–4575.
   PubMedGoogle Scholar
• Grassman, R., C. Dengler, I. Muller-Fleckenstein, K. McGuire, M. C. Dokhler, J. G. Sodroski, and W. A. Haseltine. 1989. Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA 86:3351–3355.
   PubMed Web of Science ®Google Scholar
• Gregersen, P. K. 1989. HLA class II polymorphism: implications for genetic susceptibility to autoimmune disease. Lab. Invest. 61:5–19.
   PubMed Web of Science ®Google Scholar
• Hall, W., C. R. Liu, O. Schneewind, H. Takahashi, M. H. Kaplan, G. Roupe, and A. Vahlne. 1991. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 253:317–320.
   PubMed Web of Science ®Google Scholar
• Hasan, S., T. Koda, and M. Kakinuma. 1994. An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J. Biol. Chem. 269:25042–25048.
   PubMedGoogle Scholar
• Hasunuma, T., T. Nakajima, H. Ano et al. 1994. Establishment and characterization of synovial cell clones with integrated human T-cell leukemia virus type-I. Clin. Immunol. Immunopathol. 72:90–97.
   PubMedGoogle Scholar
• Hinrichs, S. H., M. Nerenberg, R. K. Reynolds, G. Khoury, and G. A. Jay. 1987. A transgenic mouse model for human neurofibromatosis. Science 237:1340–1343.
   PubMed Web of Science ®Google Scholar
• Hirai, H., T. Suzuki, J. Fujisawa, J. Inoue, and M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91:3584–3588.
   PubMed Web of Science ®Google Scholar
• Hiscott, J., L. Petropoulos, and J. Lacoste. 1995. Molecular interactionsbetween HTLV-I Tax protein and the NF-kappa B transcription complex. Virology 214:3–11.
   PubMedGoogle Scholar
• Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163–168.
   PubMed Web of Science ®Google Scholar
• Iwakura, Y., S. Saijo, Y. Kioka, J. Nakayama-Yamada, K. Itagaki, M. Tosu, M. Asano, Y. Kanai, and K. Kakimoto. 1995. Autoimmunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. J. Immunol. 155:1588–1598.
   PubMed Web of Science ®Google Scholar
• Jacobson, S., H. Shida, D. E. McFarlin, A. S. Fauci, and S. Koenig. 1990. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I in patients with HTLV-I-associated neurological disease. Nature (London) 348:245–248.
   PubMed Web of Science ®Google Scholar
• Jacobson, S., J. S. Reuben, R. D. Streilein, and T. J. Palker. 1991. Induction of CD4 +, human T lymphotropic type-I-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-I. J. Immunol. 146:1155–1162.
   Google Scholar
• Kannagi, M., S. Matsushita, H. Shida, and S. Harada. 1994. Cytotoxic T cell response and expression of the target antigen in HTLV-infection. Leukemia 8(Suppl. 1):S54–S59.
   PubMedGoogle Scholar
• Kanno, T., K. Brown, G. Franzoso, and U. Siebenlist. 1994. Evidence in support of a role for human T-cell leukemia virus type I Tax in activating NF-kappa B via stimulation of signaling pathways. Mol. Cell. Biol. 14:6443–6451.
   PubMed Web of Science ®Google Scholar
• Kimata, J. T., and L. Ratner. 1991. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J. Virol. 65:4398–4407.
   PubMedGoogle Scholar
• Kinoshita, T., A. Tsujimoto, K. Shimotohno, and T. Sugimura. 1991. Sequence variations in LTR and env regions of HTLV-I do not discriminate between the virus from patients with HTLV-I-associated myelopathy and adult T-cell leukemia. Int. J. Cancer 47:491–495.
   PubMedGoogle Scholar
• Kira, J., Y. Itoyama, Y. Koyanagi, J. Tateishi, M. Kishikawa, S. Akizuki, I. Kobayashi, N. Toki, K. Sueishi, H. Sato et al. 1992. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann. Neurol. 31:39–45.
   PubMedGoogle Scholar
• LaGrenada, L., B. Hanchard, V. Fletcher, B. Cranston, and W. Blattner. 1990. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 336:1345–1347.
   PubMedGoogle Scholar
• Lehky, T. J., E. P. Cowan, L. A. Lampson, and S. Jacobson. 1994. Induction of HLA class I and II expression in human T-lymphotropic virus type I-in-fected neuroblastoma cells. J. Virol. 68:1854–1863.
   PubMed Web of Science ®Google Scholar
• Lindholm, P. F., F. Kashanchi, and J. N. Brady. 1993. Transcriptional regulation in the human retrovirus HTLV-I. Semin. Virol. 4:53–60.
   Google Scholar
• Li-Weber, M., I. V. Davydov, H. Krafft, and P. H. Krammer. 1994. The role of NF-Y and IRF-2 in the regulation of human IL-4 gene expression. J. Immunol. 153:4122–4133.
   PubMedGoogle Scholar
• Luckow, B., and G. Schutz. 1987. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:5490.
   PubMed Web of Science ®Google Scholar
• Mach, B. 1995. MHC class II regulation-lessons from a disease. N. Engl. J. Med. 332:120–122.
   PubMedGoogle Scholar
• Maity, S. N., S. Sinha, E. C. Ruteshousher, and B. de Crombrugghe. 1992. Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J. Biol. Chem. 267:16574–16580.
   PubMedGoogle Scholar
• Mann, D. L., P. DeSantis, G. Mark, A. Pfeifer, M. Newman, N. Gibbs, M. Popovic, M. G. Sarngadharan, R. C. Gallo, J. Clark, and W. Blattner. 1987. HTLV-I associated B-cell CLL: indirect role for retrovirus in leukemogen-esis. Science 236:1103–1106.
   PubMed Web of Science ®Google Scholar
• Marcil, R., and D. R. Higgins. 1992. Direct transfer of plasmid DNA from yeast to E. coli by electroporation. Nucleic Acids Res. 20:917.
   PubMedGoogle Scholar
• Matsuzaki, Y., J.-I. Fujisawa, and M. Yoshida. 1995. Identification of transcriptional activation domain of TREB5, a CREB/ATF family protein that binds to HTLV-1 enhancer. J. Biochem. 117:303–308.
   PubMedGoogle Scholar
• Matthews, M.-A. H., R.-B. Markowitz, and W. S. Dynan. 1992. In vitro activation of transcription by the human T-cell leukemia virus type I Tax protein. Mol. Cell. Biol. 12:1986–1996.
   PubMedGoogle Scholar
• McKinsey, T. A., J. A. Brockman, D. C. Scherer, S. W. Al-Murrani, P. L. Green, and D. W. Ballard. 1996. Inactivation of IKBβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kB. Mol. Cell. Biol. 16:2083–2090.
   Google Scholar
• Monaco, J. J. 1993. Structure and function of genes in the MHC class II region. Curr. Opin. Immunol. 5:17–20.
   PubMedGoogle Scholar
• Mori, M., B. Nobutaro, and K. Kinoshita. 1988. Familial occurrence of HTLV-associated myelopathy. Ann. Neurol. 23:100.
   PubMedGoogle Scholar
• Mukhopadhyaya, R., and M. R. Sadaie. 1993. Nucleotide sequence analysis of HTLV-I isolated from cerebrospinal fluid of a patient with TSP/HAM. Comparison to other HTLV-I isolates. AIDS Res. Hum. Retroviruses 9:109–114.
   PubMedGoogle Scholar
• Munoz, E., and A. Israel. 1995. Activation of NF-kappa B by the Tax protein of HTLV-I. Immunobiol. 193:128–136.
   PubMed Web of Science ®Google Scholar
• Nerenberg, M., S. Hinrichs, R. Reynolds, G. Khoury, and G. A. Jay. 1987. The tat gene of human T-lymphotropic virus type I induces mesenchymal tumors in transgenic mice. Science 237:1324–1329.
   PubMed Web of Science ®Google Scholar
• Nishioka, K., I. Maruyama, K. Sato, I. Kitajima, Y. Nakajima, and M. Osame. 1989. Chronic inflammatory arthropathy associated with HTLV-I. Lancet i:441.
   Google Scholar
• Noraz, N., B. Verrier, C. Fraisier, and C. Desgranges. 1995. Cell surface phenotype changes induced in H9 T cells chronically infected with HTLV type I or HIV type I or coinfected with the two viruses. AIDS Res. Hum. Retroviruses 11:145–154.
   PubMed Web of Science ®Google Scholar
• Ohshima, K., M. Kikuchi, Y. Masuda, Y. Sumiyoshi, F. Eguchi, H. Mohtai, M. Takeshita, and N. Kimura. 1992. Human T-cell leukemia virus type I associated lymphadenitis. Cancer 69:239–248.
   PubMed Web of Science ®Google Scholar
• Paca-Uccaralertkun, S., L.-J. Zhao, N. Adya, J. V. Cross, B. R. Cullen, I. Boros, and C.-Z. Giam. 1994. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol. Cell. Biol. 14:456–462.
   PubMedGoogle Scholar
• Pozzatti, R., J. Vogel, and G. A. Jay. 1990. The human T lymphotropic virus type I tax gene can cooperate with ras oncogene to induce neoplastic transformation in cells. Mol. Cell. Biol. 10:413–417.
   PubMedGoogle Scholar
• Reith, W., V. Steimle, B. Durand, M. Kobr, and B. Mach. 1995. Regulation of MHC class II gene expression. Immunobiology 193:248–253.
   PubMed Web of Science ®Google Scholar
• Reith, W., C.-A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554–558.
   PubMedGoogle Scholar
• Sartoris, S., and R. S. Accolla. 1995. Transcriptional regulation of MHC class II genes. Int. J. Clin. Lab. Res. 25:71–78.
   PubMedGoogle Scholar
• Schmidt, E. E., and U. Schibler. 1995. Cell size regulation, a mechanism that controls cellular RNA accumulation: consequences on regulation of the ubiquitous transcription factors Oct1 and NF-Y and the liver-enriched transcription factor DBP. J. Cell Biol. 128:467–483.
   PubMed Web of Science ®Google Scholar
• Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res. 17:6419.
   PubMed Web of Science ®Google Scholar
• Scott, M. L., T. Fujita, H.-C. Liou, G. P. Nolan, and D. Baltimore. 1993. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 7:1266–1276.
   PubMed Web of Science ®Google Scholar
• Shirabe, S., T. Nakamura, M. Tsujihata, S. Nagataki, M. Seiki, and M. Yoshida. 1990. Retrovirus from human T-cell leukemia virus type I associated myelopathy is the same strain as a prototype human T-cell leukemia virus type I. Arch. Neurol. 47:1258–1260.
   PubMedGoogle Scholar
• Sinha, S., I.-S. Kim, K.-Y. Sohn, B. de Crombrugghe, and S. N. Maity. 1996. Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol. Cell. Biol. 16:328–337.
   PubMedGoogle Scholar
• Sinha, S., S. N. Maity, J. Lu, and B. de Crombrugghe. 1995. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc. Natl. Acad. Sci. USA 92:1624–1628.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., and W. C. Greene. 1991. Type I human T-cell leukemia virus Tax protein transforms rat fibroblasts through the cyclic adenosine mono-phosphate response element binding protein/activating transcription factor pathway. J. Clin. Invest. 88:1038–1042.
   PubMed Web of Science ®Google Scholar
• Smith, M. R., and W. C. Greene. 1990. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875–1885.
   PubMed Web of Science ®Google Scholar
• Stone, D. M., A. J. Hof, and W. C. Davis. 1995. Up-regulation of IL-2 receptor alpha and MHC class II expression on lymphocyte subpopulations from bovine leukemia virus infected lymphocytotic cows. Vet. Immunol. Immunopathol. 48:65–76.
   PubMedGoogle Scholar
• Sun, S.-C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259:1912–1915.
   PubMed Web of Science ®Google Scholar
• Suzuki, T., J.-I. Fujisawa, M. Toita, and M. Yoshida. 1993. The trans-activator tax of human T-cell leukemia virus type I (HTLV-I) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-I. Proc. Natl. Acad. Sci. USA 90:610–614.
   PubMed Web of Science ®Google Scholar
• Tanka, A., C. Takahashi, S. Yamaoka, T. Nosaka, M. Maki, and M. Hatanaka. 1990. Oncogenic transformation by the Tax gene of human T-cell leukemia virus type I in vitro. Proc. Natl. Acad. Sci. USA 87:1071–1075.
   PubMedGoogle Scholar
• Wagner, S., and M. R. Green. 1993. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262:395–399.
   PubMed Web of Science ®Google Scholar
• Wright, K. L., B. J. Vilen, Y. Itoh-Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. Badley Clarke, and J. P.-Y. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13:4042–4053.
   PubMedGoogle Scholar
• Yamaoka, S., H. Inoue, M. Sakurai, T. Sugiyama, M. Hazama, T. Yamada, and M. Hatanaka. 1996. Constitutive activation of NF-κB is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 15:873–887.
   PubMedGoogle Scholar
• Yoshida, M. 1993. HTLV-I Tax: regulation of gene expression and disease. Trends Microbiol. 1:131–135.
   PubMedGoogle Scholar
• Yoshida, M., M. Osame, K. Usuki, M. Matsumoto, and A. Igata. 1987. Virus detected in HTLV-I-associated myelopathy and adult T-cell leukemia are identical on DNA blotting. Lancet i:1085–1086.
   Google Scholar
• Yoshida, M., M. Osame, H. Kawai, M. Toita, N. Kuwasaki, Y. Nishida, Y. Hiraki, K. Takahashi, K. Nomura, S. Sonoda et al. 1989. Increased replication of HTLV-I in HTLV-associated myelopathy. Ann. Neurol. 26:331–335.
   PubMed Web of Science ®Google Scholar
• Zeleznik-Le, N. J., J. C. Azizkhan, and J. P.-Y. Ting. 1991. Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873–1837.
   PubMedGoogle Scholar
• Zervos, A. S., J. Gyuris, and R. Brent. 1993. Mix1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:223–232.
   PubMed Web of Science ®Google Scholar
• Zhao, L.-J., and C.-Z. Giam. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA 89:7070–7074.
   PubMed Web of Science ®Google Scholar
• Zhao, T. M., M. A. Robinson, F. S. Bowers, and T. J. Kindt. 1995. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J. Virol. 69:2024–2030.
   PubMed Web of Science ®Google Scholar
• Zwicker, J., C. Gross, F. C. Lucibello, M. Truss, F. Ehlert, K. Engeland, and R. Muller. 1995. Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res. 23:3822–3830.
   PubMedGoogle Scholar